跳至主要内容
临床试验/CTRI/2025/01/078958
CTRI/2025/01/078958尚未招募2 期

Comparison of efficacy of adjunctive oral levetiracetam and topiramate for focal onset seizures in children aged 2-18 years: a randomized controlled trial

Dr Ashish Jha1 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2025年1月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
138
试验地点
1
主要终点
Proportion of participants with seizure freedom

研究概览

简要总结

This will be an open-labeled two-arm parallel design randomized controlled trial, which will compare the efficacy of oral levetiracetam and topiramate in children with focal epilepsy aged 2-18 years. At the end of 12 weeks, we will compare the number of participants with seizure freedom and the number of participants  requiring additional anti-seizure medication.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
2.00 Year(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • Children with focal epilepsy Seizures uncontrolled on one anti-seizure medication.

排除标准

  • Children already receiving oral topiramate or levetiracetam Coexistent generalized seizures.

结局指标

主要结局

Proportion of participants with seizure freedom

时间窗: 12 weeks

次要结局

  • Number of participants requiring additional ASM(12 weeks)

研究者

发起方
Dr Ashish Jha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Ashish Jha

All India Institute of Medical Sciences, Rishikesh

研究点 (1)

Loading locations...

相似试验